Preview: What to expect from chancellor Rishi Sunak

How a post-pandemic budget will balance cutting national debt with key spending allocations

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

269.94+5.14 (+1.94%)

At close: 4:00PM EDT

269.97 +0.03 (+0.01%)
Pre-market: 09:26AM EDT

Currency in USD

Earnings estimate	Current qtr. (Sep 2021)	Next qtr. (Dec 2021)	Current year (2021)	Next year (2022)
No. of analysts	23	23	26	26
Avg. Estimate	4.13	3.43	18.62	20.88
Low estimate	3.65	1.93	17.5	15.82
High estimate	4.69	4.36	19.16	25.77
Year ago EPS	8.84	4.58	33.7	18.62

Revenue estimate	Current qtr. (Sep 2021)	Next qtr. (Dec 2021)	Current year (2021)	Next year (2022)
No. of analysts	22	22	27	27
Avg. Estimate	2.67B	2.62B	10.77B	11.2B
Low estimate	2.6B	2.54B	10.65B	10.34B
High estimate	2.78B	2.72B	10.9B	14.59B
Year ago sales	N/A	2.85B	13.44B	10.77B
Sales growth (year/est)	N/A	-8.20%	-19.90%	4.10%

Earnings history	29/09/2020	30/12/2020	30/03/2021	29/06/2021
Est. EPS	8.04	4.87	5.04	4.54
Actual EPS	8.84	4.58	5.34	5.68
Difference	0.8	-0.29	0.3	1.14
Surprise %	10.00%	-6.00%	6.00%	25.10%

EPS trend	Current qtr. (Sep 2021)	Next qtr. (Dec 2021)	Current year (2021)	Next year (2022)
Current estimate	4.13	3.43	18.62	20.88
7 days ago	4.15	3.49	18.7	20.91
30 days ago	4.15	3.5	18.71	20.92
60 days ago	4.59	4.04	18.59	20.98
90 days ago	4.61	4.09	18.72	20.95

EPS revisions	Current qtr. (Sep 2021)	Next qtr. (Dec 2021)	Current year (2021)	Next year (2022)
Up last 7 days	N/A	N/A	N/A	N/A
Up last 30 days	N/A	N/A	1	N/A
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	N/A	1	1

Growth estimates	BIIB	Industry	Sector(s)	S&P 500
Current qtr.	-53.30%	N/A	N/A	N/A
Next qtr.	-25.10%	N/A	N/A	N/A
Current year	-44.70%	N/A	N/A	N/A
Next year	12.10%	N/A	N/A	N/A
Next 5 years (per annum)	-8.02%	N/A	N/A	N/A
Past 5 years (per annum)	16.89%	N/A	N/A	N/A